Yihan Mao

Yihan Mao

Auto-generated profile, based on publicly available information

Yihan Mao

The Third Clinical School of Medicine Capital Medical University Beijing China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
YMYihan Mao
Yihan Mao
QSQiucheng Shi
Qiucheng Shi
PZPing Zhang
Ping Zhang
YJYan Jiang
Yan Jiang
YYYunsong Yu
Yunsong Yu
Tigecycline is an antibacterial restricted for use against carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to identify the tigecycline-resistance mechanism in clinical CRKP isolates obtained from a 60-year-old female during tigecycline treatment. Three K. pneumoniae isolates obtained during tigecycline treatment were subjected to antimicrobial susceptibility testing (AST), pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), whole-genome sequencing and analyzing. The function of ramR was confirmed by gene complementation. Three K. pneumoniae isolates named W814, W112, and W113 were collected on days 0, 10 and 13 respectively, from an ongoing tigecycline treatment. The AST results showed resistance to all antibiotics except tigecycline and ceftazidime/avibactam. The tigecycline minimum inhibitory concentration (MIC) for W814 and W112 was 4 mg/L, compared to W113 MIC of 16 mg/L. These three strains belonged to ST11 and their PGFE analysis showed a similar pattern. The ISKpn18 insertion sequence (IS) in ramR was identified in W113. A parent strain transformed with the plasmid pCR2.1-Hyg carrying ramR enhanced tigecycline susceptibility, thus confirming that loss-of-function insertion in ramR contributes to tigecycline resistance. ISKpn18 insertion in the ramR gene contributes to the tigecycline-resistance mechanism in the isolated K. pneumoniae strains.

31 May 2024 in Cancer Medicine
Verified
Journal Article
Open access
SFshanshan fan
shanshan fan
YMYihan Mao
Yihan Mao
YGYang Ge
Yang Ge
ZLZiwei Liang
Ziwei Liang
Background: Biliary tract cancers have garnered significant attention due to their highly malignant nature. The relationship between abnormal lipid metabolism and tumor occurrence and development is a research hotspot. However, its correlation with biliary tract cancers is unclear.Methods: We enrolled 78 patients with biliary tract cancers and obtained data on clinical characteristics, pathological findings, and preoperative blood lipid indices, including total cholesterol (TC), high‐density lipoprotein cholesterol (HDL‐C), low‐density lipoprotein cholesterol (LDL‐C), triglycerides (TG), and lipoprotein (a) [Lp(a)]. Receiver operating characteristic (ROC) curves were used to determine the optimal predictive cutoff values of lipid indicators among the participants. Independent risk factors were determined using Cox regression, and survival was predicted using the Kaplan–Meier method. Statistical analyses were performed using SPSS software.Results: Univariate Cox regression analysis revealed that the body mass index (BMI), tumor location, surgical margin, N stage, and abnormally increased LDL‐C, TG, and Lp(a) levels were significantly associated with poor prognosis of biliary tract cancers (p < 0.05). Multifactor Cox regression demonstrated that only N stage (HR = 3.393, p < 0.001) and abnormally increased Lp(a) levels (HR = 2.814, p = 0.004) were significantly associated with shorter survival. N stage and Lp(a) were identified as independent prognostic risk factors for patients with biliary tract cancers.Conclusion: This study presents Lp(a) as a novel biochemical marker that can guide clinical treatment strategies for patients with biliary tract cancers. More effective treatment options and intensive postoperative testing should be considered to prolong the survival of these patients with preoperative abnormal lipid metabolism.